Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 16363/0444.
Meropenem 500 mg and 1 g Powder for Solution for Injection or Infusion
Meropenem 500 mg powder for solution for injection or infusion
Meropenem 1 g powder for solution for injection or infusion
meropenem
1. What Meropenem is and what it is used for
2. What you need to know before you use Meropenem
3. How to use Meropenem
4. Possible side effects
5. How to store Meropenem
6. Contents of the pack and other information
Meropenem belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria, which can cause serious infections.
Meropenem is used to treat the following in adults and children aged 3 months and older:
Meropenem may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
Meropenem may be used to treat bacterial infection of the blood which might be associated with a type of infection mentioned above.
Talk to your doctor, pharmacist or nurse before using Meropenem.
You may develop a positive test (Coombs test) which indicates the presence of antibodies that may destroy red blood cells. Your doctor will discuss this with you.
You may develop signs and symptoms of severe skin reactions (see section 4). If this happens talk to your doctor or nurse immediately so that they can treat the symptoms.
Liver problems
If you notice yellowing of the skin and eyes, itchy skin, dark-coloured urine or light-coloured stool tell your doctor. This may be a sign of liver problems which your doctor needs to check.
If you are not sure if any of the above applies to you, talk to your doctor or nurse before using Meropenem.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
This is because Meropenem can affect the way some medicines work and some medicines can have an effect on Meropenem.
In particular, tell your doctor or nurse if you are taking any of the following medicines:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. It is preferable to avoid the use of meropenem during pregnancy. Your doctor will decide whether you should use meropenem.
It is important that you tell your doctor if you are breast-feeding or if you intend to breast-feed before receiving meropenem. Small amounts of this medicine may pass into the breast milk. Therefore, your doctor will decide whether you should use meropenem while breast-feeding.
No studies on the effect on the ability to drive and use machines have been performed. Meropenem has been associated with headache; tingling or pricking skin (paraesthesia). Any of these side effects could affect your ability to drive or operate machines.
Meropenem may cause and involuntary muscle movements, leading the person's body to shake rapidly and uncontrollably (convulsions). This is usually accompanied with a loss of consciousness. Do not drive or use machines if you experience this side effect.
The maximum recommended daily dose of this medicinal product contains 540 mg sodium (found in table salt). This is equivalent to 27% of the adult recommended maximum daily dietary intake for sodium.
Meropenem 500 mg
Talk to your doctor if you need 9 or more vials daily for a prolonged period, especially if you have been advised to follow a low salt (sodium) diet.
Meropenem 1 g
Talk to your doctor if you need 5 or more vials daily for a prolonged period, especially if you have been advised to follow a low salt (sodium) diet.
Always use this medicine exactly as your doctor or nurse has told you. Check with your doctor or nurse if you are not sure.
If you accidentally use more than your prescribed dose, contact your doctor or nearest hospital straight away.
If you miss an injection, you should have it as soon as possible. However, if it is almost time for your next injection, skip the missed injection. Do not take a double dose (two injections at the same time) to make up for a forgotten dose.
Do not stop having Meropenem until your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you have any of these signs and symptoms, tell your doctor or nurse straight away. You may need urgent medical treatment. The signs and symptoms may include a sudden onset of:
Damage to red blood cells (not known)
The signs include:
If you notice any of the above, see a doctor straight away.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Sudden chest pain, which may be a sign of a potentially serious allergic reaction called Kounis syndrome has been noted with other medicines of the same type. If this happens talk to a doctor or nurse immediately.
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on vial label and carton after EXP. The expiry date refers to the last day of that month.
The medicinal product does not require any special storage condition.
After reconstitution: The reconstituted solutions for intravenous injection should be used immediately. The time interval between the beginning of reconstitution and the end of intravenous injection should not exceed:
Do not freeze the reconstituted solution.
After reconstitution: The reconstituted solutions for intravenous infusion should be used immediately. The time interval between the beginning of reconstitution and the end of intravenous infusion should not exceed:
From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbiological contamination, the product should be used immediately.
If not used immediately in-use storage times and conditions are the responsibility of the user.
Do not freeze the reconstituted solution.
Do not throw away any medicines via waste water or house hold waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Meropenem is a white to pale yellow crystalline powder for solution for injection or infusion in vial.
Product after reconstitution is clear colourless to yellow solution.
Meropenem 500 mg:
674.78 mg powder in a 30ml Type-I, tubular, clear glass vial with stopper (bromobutyl rubber with aluminum seals having taxim blue colour polypropylene discs).
Meropenem 1 g:
1349.56 mg powder in a 40ml Type-I, tubular, clear glass vial with stopper (bromobutyl rubber with aluminum seals having white colour polypropylene discs).
The medicinal product is supplied in pack sizes of 1 or 10 vials.
Not all pack sizes may be marketed.
or
This leaflet was last revised in 08/2025.
N03663XX